Frank Jaksch

Frank Jaksch is a renowned chemist, entrepreneur, and co-founder of ChromaDex Corporation. He studied Chemistry-Biology at Valparaiso University, where he developed a deep understanding of natural products, new ingredient development, analytical chemistry, reference standards, quality control, and process development. With his extensive experience in the field, Jaksch has become a leading authority on NAD and Nicotinamide Riboside (NR), two of ChromaDex's core focuses.

ChromaDex is a global nutraceutical company dedicated to improving the way people age through science-based ingredients. They work with leading universities and research institutions worldwide, including Harvard Medical School, to uncover the full potential of NAD and NR. Jaksch's flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRUNIAGEN, has extensive clinical and scientific research backing its efficacy, and is helping the world AGE BETTER.

In addition to his role at ChromaDex, Jaksch has also served as an Advisory Board Member at Yuva Biosciences, Inc. and Board Member at Natural Products Association. Before co-founding ChromaDex, he was the International Subsidiaries Manager at Phenomenex and had a Quality Control position at ICN Pharmaceuticals. With his extensive experience in the field, Jaksch is a go-to source for information on natural products, new ingredient development, analytical chemistry, reference standards, quality control, and process development.